drugset / Trial / NCT04820101

Dexmedetomidine for LISA Procedure in Preterm Infants

NCT04820101 ↗

Unknown 40 enrolled University of Padova
NaSingle-groupOpen-labelTreatment

Summary

The investigators aim to evaluate: the effectiveness of dexmedetomidine for analgesia and sedation during LISA procedure, without compromising the respiratory drive; the safety of this drug on the preterm infant in a pilot study.

Timeline

Start
2021-05-15
Primary completion
2023-04-01
Completion
2023-04-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 1 ug/kg Intravenous

Indications

No indication recorded.